LT-IVAX®

Fowl Laryngotracheitis Vaccine

Product Description

LT-Ivax® vaccine is a live virus vaccine containing a carefully selected infectious laryngotracheitis virus strain modified by passage in tissue culture. This vaccine contains a very mild attenuated virus.

Indications

This product has been shown to be effective for the vaccination of healthy chickens 4 weeks of age or older against infectious fowl laryngotracheitis.

Advantages*

  • Solid and uniform protection against infectious laryngotracheitis when administered via eye-drop
  • Safe – more attenuated than CEO vaccines, has not been associated with vaccine induced outbreaks
  • Has been shown to not spread from bird to bird in challenge-based contact-controlled studies

Diseases/Parasites

Vaccination Programs

Many factors must be considered in determining the vaccination program for a particular farm or poultry operation. To be fully effective, the vaccine must be administered to healthy receptive birds held in proper environment under good management. In addition, the response may be modified by the age of the birds and their immune status. Seldom does 1 vaccination under field conditions produce complete protection for all individuals in a given flock. The amount of protection required will vary with the type of operation and the degree of exposure that a flock is likely to encounter.

Contraindications

The application of Newcastle Disease or Bronchitis vaccines, either singly or in combination should be avoided for a three-day period prior to and for three days after the application of LT-IVAX.

Intraocular Administration

FOR CHICKENS 4 WEEKS (INITIAL) AND 10 WEEKS (REVACCINATION) OF AGE
Place one full drop of vaccine into the open eye. Do not release the bird until after it has swallowed.

Supplied

1 x 1,000 doses

Caution

1. VACCINATE ONLY HEALTHY CHICKENS.
2. An eye reaction may be noticed if birds are incubating coryza or other infectious organisms, or if there is excess ammonia or dust in the air of the housing facilities.
3. In outbreak situations, vaccinate healthy birds first, progressing toward outbreak areas in order to vaccinate diseased birds last.
4. Use entire contents when first opened.
5. Do not vaccinate within 21 days before slaughter.
6. Store at 2° to 8° C (35° to 46° F).
7. Inactivate unused contents before disposal.
8. Do not mix with other products, except as specified on this label.
9. In case of human exposure, contact a physician.
10. Contains gentamicin as a preservative.
11. FOR ANIMAL USE ONLY.

Notice

This vaccine has undergone rigid potency, safety and purity tests, and meets Merck Animal Health, U.S. and local regulatory requirements. It is designed to stimulate effective immunity when used as directed, but the user must be advised that the response to the product depends upon many factors, including, but not limited to, conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of the individual chickens and the degree of field exposure. Therefore, directions should be followed carefully. A safety data sheet (SDS) is available upon request. This and any other consumer information can be obtained by calling Merck Animal Health Customer Service at 1-800-211-3573.

Records

Keep a record of vaccine, quantity, serial number, expiration date, and place of purchase; the date and time of vaccination; the number, age, breed, and locations of chickens; names of operators performing the vaccination and any observed reactions.

Contact our sales or technical services representatives to help design a custom vaccination program.

Resources

INNOVAX®-ND-ILT and LT-IVAX® Efficacy

Protection against virulent infectious Laryngotracheitis virus in long-life birds

Download

No items to show.

Loading…

For additional information, please see the product label.
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

*Data on file, Merck Animal Health

To view our complete product lineup, click to view our
POULTRY PRODUCT CATALOG vol. 3.1.